Stocks · Health care · Biological Products, (No Diagnostic Substances)

C4 Therapeutics, Inc.

CCCC Clue Score37
United States Fiscal year ends December CIK 0001662579 Results filed 5 Nov 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
Kenneth Carl Anderson
1 Jun 2026
Director
Exercised, kept
1,070
$2.11
$2.26K
Leonard Reyno
16 Jan 2026
Chief Medical Officer
Sell
10,000
$2.22
$22.20K

What was left out

Form 4 filings counted 27
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 1
Transactions with no price 0
Shares from compensation/vesting 2,289,069
History held since 5 Oct 2020